Want to see IL:IDIN full AI Analyst Report?
Top Page
Idi Insur
(TASE:IDIN)
Select Model
Select Model
Rating:71Outperform
Price Target:
26,741.00
▲(7.61% Upside)
Action:Upgraded
Date:05/30/26
The score is driven primarily by solid financial performance (strong profitability and ROE, tempered by cash-flow volatility and higher leverage) and an attractive valuation (low P/E and high dividend yield). Technical indicators are neutral-to-soft, with a negative MACD limiting the overall score despite otherwise balanced momentum readings.
Positive Factors
High return on equity and strong profitability
ROE in the upper-20s to ~30% signals durable underwriting or investment economics and efficient capital deployment. Sustained high ROE supports reinvestment, dividend capacity and competitive positioning in the diversified insurance space, underpinning long-term shareholder returns.
Negative Factors
Volatile cash flows across periods
Intermittent negative and sharply swinging free cash flow reduces predictability of internal funding for claims, reinsurance and capital returns. This volatility makes multi-year planning harder, may force external financing in stress, and raises execution risk through underwriting or investment cycles.
Read all positive and negative factors
Positive Factors
Negative Factors
High return on equity and strong profitability
ROE in the upper-20s to ~30% signals durable underwriting or investment economics and efficient capital deployment. Sustained high ROE supports reinvestment, dividend capacity and competitive positioning in the diversified insurance space, underpinning long-term shareholder returns.
Read all positive factors
Idi Insur (IDIN) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪3.58B
Dividend Yield7.27%
Average Volume (3M)41.54K
Price to Earnings (P/E)9.8
Beta (1Y)1.15
Revenue Growth9.90%
EPS Growth22.54%
CountryIL
Employees1,670
SectorGeneral
Sector StrengthN/A
IndustryInsurance - Diversified
Share Statistics
EPS (TTM)24.71
Shares Outstanding14,787,986
10 Day Avg. Volume35,082
30 Day Avg. Volume41,536
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)2.81
Price to Sales (P/S)0.88
P/FCF Ratio4.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Idi Insur Business Overview & Revenue Model
Company Description
I.D.I. Insurance Company Ltd. provides insurance products and services to individuals and corporate customers in Israel. It operates through General Insurance, Health Insurance, and Life Insurance and Long-Term Savings segments. The company offers...
How the Company Makes Money
null...
Idi Insur Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
72
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.81B | 4.04B | 3.52B | 2.73B | 2.20B | 2.16B |
| Gross Profit | 3.55B | 4.04B | 3.02B | 2.29B | 1.80B | 1.77B |
| EBITDA | 701.23M | 684.12M | 497.95M | 307.21M | 211.56M | 391.05M |
| Net Income | 364.83M | 356.94M | 257.08M | 139.21M | 84.44M | 201.20M |
Balance Sheet | ||||||
| Total Assets | 6.54B | 6.79B | 7.13B | 6.44B | 6.20B | 6.30B |
| Cash, Cash Equivalents and Short-Term Investments | 128.92M | 264.05M | 98.45M | 257.87M | 253.20M | 705.96M |
| Total Debt | 787.27M | 788.22M | 583.86M | 541.92M | 69.88M | 73.24M |
| Total Liabilities | 5.26B | 5.52B | 6.14B | 5.52B | 5.35B | 5.44B |
| Stockholders Equity | 1.28B | 1.27B | 988.82M | 926.00M | 855.52M | 862.16M |
Cash Flow | ||||||
| Free Cash Flow | 446.74M | 864.30M | 48.20M | 95.93M | -211.78M | 372.32M |
| Operating Cash Flow | 487.23M | 887.76M | 143.42M | 193.65M | -130.23M | 456.43M |
| Investing Cash Flow | -107.77M | -110.89M | -91.94M | -97.65M | -79.02M | -98.57M |
| Financing Cash Flow | 20.75M | -39.16M | -211.99M | -93.05M | -244.47M | -11.54M |
Idi Insur Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₪29.93B | 12.24 | ― | 3.18% | 43.27% | 99.24% | |
72 Outperform | ₪18.43B | 9.66 | ― | ― | 35.50% | 147.32% | |
71 Outperform | ₪3.58B | 9.79 | ― | 7.08% | 9.90% | 22.54% | |
66 Neutral | ₪18.84B | 8.03 | ― | 2.07% | -30.11% | 110.97% | |
66 Neutral | ₪43.34B | 12.86 | ― | 3.14% | 28.82% | 58.47% | |
65 Neutral | ₪36.11B | 11.86 | 23.23% | 3.92% | 28.54% | 147.51% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IL:IDIN
Idi Insur
24,280.00
6,380.81
35.65%
IL:CLIS
Clal Insurance
23,580.00
7,989.47
51.25%
IL:HARL
Harel
17,940.00
8,363.56
87.33%
IL:MGDL
Migdal Insur.
1,795.00
761.00
73.60%
IL:PHOE
Phoenix
17,440.00
6,517.76
59.67%
IL:MMHD
Menora Miv Hld
49,130.00
21,154.79
75.62%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.